人间充质干细胞共过表达hsa-miR-145-5p与hsa-miR-31-5p抑制胶质母细胞瘤细胞侵袭
本研究将人骨髓来源间充质干细胞(hMSC)工程化,使其分泌抑制胶质瘤侵袭的微小RNA(miRNA),并在体外、离体及体内模型中验证。共转染hsa-miR-145-5p与hsa-miR-31-5p的hMSC使U87细胞侵袭降至对照的60.7%,器官型大鼠脑片中共植入时相对侵袭面积减少37.1%。作者认为多miRNA共过表达可能是有用的新型治疗策略,hMSC可作为miRNA递送载体。
要点
- 共转染hsa-miR-145-5p与-31-5p的hMSC使U87细胞侵袭降至对照的60.7%,呈接触依赖方式。
- U87细胞与共转染hMSC共植入器官型大鼠脑片纹状体后相对侵袭面积减少37.1%。
- 全基因组芯片显示共过表达hsa-miR-145-5p与-31-5p下调U87细胞FSCN1表达。
核心结论
- 作者认为,hMSC过表达miRNA可通过接触依赖转移改变胶质瘤细胞功能,多miRNA共过表达可能是有用的新型治疗策略,hMSC可作为miRNA的递送载体。
研究设计与样本
- 研究将hMSC工程化以分泌抑制胶质瘤细胞侵袭的miRNA,并在体外、离体及体内模型中检测其向胶质瘤细胞递送miRNA的潜力。
- 在体外和离体共培养中检测hMSC对U87胶质瘤细胞侵袭的影响,并用Matrigel侵袭实验评估hMSC对U87细胞的趋向性。
- 在胶质瘤细胞系U251和LN229中于体内评估hMSC的趋向性及共转染hMSC的侵袭情况。
- 将U87细胞与共转染hsa-miR-145与-31-5p的hMSC共植入器官型大鼠脑片纹状体,评估相对侵袭面积。
- 对58,341个基因的表达水平进行全基因组芯片分析,检测U87细胞中FSCN1表达变化。
主要发现
- 共培养中,共转染hsa-miR-145-5p与-31-5p的hMSC在体外和离体均以接触依赖方式使U87胶质瘤细胞侵袭明显减少,U87细胞对共转染这2种miRNA的hMSC的侵袭降至对照细胞的60.7%。
- Matrigel侵袭实验显示hMSC对U87细胞的趋向性未受影响。
- 在胶质瘤细胞系U251和LN229中,hMSC在体内表现出趋向性,共转染hsa-miR-145-5p与-31-5p的hMSC所受侵袭也显著少于对照细胞。
- U87细胞与共转染hsa-miR-145与-31-5p的hMSC共植入器官型大鼠脑片纹状体后,相对侵袭面积减少37.1%,且这些U87细胞在侵袭前沿呈现圆形形态改变。
- 对58,341个基因的全基因组芯片分析显示,共过表达hsa-miR-145-5p与-31-5p下调U87细胞中FSCN1表达。
临床怎么用
- 原文结论认为多miRNA共过表达可能是有用的新型治疗策略,并提示hMSC可作为miRNA的递送载体(作者结论)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Human bone marrow–derived mesenchymal stem cells (hMSCs) show tropism for brain tumors and may be a useful vehicle for drug or gene delivery to malignant gliomas. Recently, some microRNAs (miRNAs) have been shown to suppress the invasiveness of malignant gliomas. METHODS: To test their potential to become vehicles for the delivery of miRNA to malignant gliomas, hMSCs were engineered so that hMSC secretion of miRNAs that inhibit glioma cell invasion was enabled without altering the hMSC tropism for glioma cells. RESULTS: In coculture, hMSCs cotransfected with hsa-miR-145-5p and -31-5p miRNAs showed markedly reduced invasion by U87 glioma cells in a contact-dependent manner both in vitro and ex vivo, with invasion of hMSCs cotransfected with these 2 miRNAs by the U87 cells reduced to 60.7% compared with control cells. According to a Matrigel invasion assay, the tropism of the hMSCs for U87 cells was not affected. In glioma cell lines U251 and LN229, hMSCs exhibited tropism in vivo, and invasion of hMSCs cotransfected with hsa-miR-145-5p and -31-5p was also significantly less than that of control cells. When U87 cells were coimplanted into the striatum of organotypic rat brain slices with hMSCs cotransfected with hsa-miR-145 and -31-5p, the relative invasive area decreased by 37.1%; interestingly, these U87 cells showed a change to a rounded morphology that was apparent at the invasion front. Whole-genome microarray analysis of the expression levels of 58,341 genes revealed that the co-overexpression of hsa-miR-145-5p and -31-5p downregulated FSCN1 expression in U87 cells. CONCLUSIONS: This study demonstrates that miRNA overexpression in hMSCs can alter the function of glioma cells via contact-dependent transfer. Co-overexpression of multiple miRNAs may be a useful and novel therapeutic strategy. The study results suggest that hMSCs can be applied as a delivery vehicle for miRNAs.
引用
- Kurogi R, Nakamizo A, Suzuki SO, et al. Inhibition of glioblastoma cell invasion by hsa-miR-145-5p and hsa-miR-31-5p co-overexpression in human mesenchymal stem cells. J Neurosurg. 2018. PMID: 29521593. doi:10.3171/2017.8.JNS1788
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。